Keith C. Bible
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
- Anatomy top 0.02%
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 44
- Pituitary Gland Disorders and Treatments 7
- Oncology 31
- Cancer-related Molecular Pathways 16
- Cancer Treatment and Pharmacology 6
- Co-authors
- Yuri E. NikiforovAnna M. SawkaBryan R. HaugenGregory W. RandolphSteven I. ShermanJulie Ann SosaDavid L. StewardGerard M. Doherty
- Journals
- Journal of Clinical Oncology (11 papers)Thyroid (8 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Investigational New Drugs (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Keith C. Bible
91 papers receiving 14.7k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Endocrinology, Diabetes and Metabolism 11.5k
- Anatomy 195
- Surgery 6.1k
- Oncology 3.0k
- Health Informatics 137
Countries citing papers authored by Keith C. Bible
This map shows the geographic impact of Keith C. Bible's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith C. Bible with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith C. Bible more than expected).
Fields of papers citing papers by Keith C. Bible
This network shows the impact of papers produced by Keith C. Bible. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith C. Bible. The network helps show where Keith C. Bible may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith C. Bible, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 24 | |
| 2 | 2021 | 83 | |
| 3 | 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer Hit paper breakdown → | 2021 | 374 |
| 4 | 2020 | 4 | |
| 5 | 2020 | 56 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 57 | |
| 8 | 2017 | 49 | |
| 9 | 2017 | 28 | |
| 10 | 2017 | 3 | |
| 11 | 2015 | 10 | |
| 12 | 2014 | 34 | |
| 13 | 2013 | 93 | |
| 14 | 2013 | 38 | |
| 15 | 2011 | 35 | |
| 16 | 2010 | 330 | |
| 17 | 2007 | 89 | |
| 18 | Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. | 2001 | 74 |
| 19 | 2001 | 15 | |
| 20 | 1988 | 78 |
About Keith C. Bible
Keith C. Bible is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Genetics, Cancer Research and Genetics, having authored 94 papers that have together received 15.0k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (44 papers), BRCA gene mutations in cancer (16 papers), Cancer-related Molecular Pathways (16 papers), Adrenal and Paraganglionic Tumors (11 papers), Cancer, Hypoxia, and Metabolism (8 papers), Pituitary Gland Disorders and Treatments (7 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (11.5k citations), Anatomy (195 citations), Surgery (6.1k citations), Oncology (3.0k citations) and Health Informatics (137 citations). Keith C. Bible has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Yuri E. Nikiforov, Anna M. Sawka, Bryan R. Haugen, Gregory W. Randolph, Steven I. Sherman, Julie Ann Sosa, David L. Steward, Gerard M. Doherty, Furio Pacini and Kathryn G. Schuff. Their work appears in journals such as Journal of Clinical Oncology, Thyroid, The Journal of Clinical Endocrinology & Metabolism, Investigational New Drugs and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.